Inactive Instrument

Rozdil Capital Corporation Share Price

Equities

ROZ.P

CA7810671031

Dynamic Chart
Rozdil Capital Corporation Reports Earnings Results for the Full Year Ended February 28, 2022 CI
Thiogenesis Therapeutics, Inc. completed the acquisition of Rozdil Capital Corporation (TSXV:ROZ.P). CI
Rozdil Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2021 CI
Rozdil Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2021 CI
Rozdil Capital Corporation Announces Election of Directors CI
Rozdil Capital Corporation announced that it has received CAD 3.5 million in funding CI
Rozdil Capital Corporation announced that it has received CAD 3.5 million in funding CI
Rozdil Capital Corporation Reports Earnings Results for the First Quarter Ended May 31, 2021 CI
Rozdil Capital Corporation Reports Earnings Results for the Full Year Ended February 28, 2021 CI
Rozdil Capital Corporation announced that it expects to receive CAD 2.8 million in funding CI
Rozdil Capital Corporation Reports Earnings Results for the Third Quarter Ended November 30, 2020 CI
Thiogenesis Therapeutics, Inc. entered into a non-binding letter of intent to acquire Rozdil Capital Corporation (TSXV:ROZ.P) in a reverse merger transaction for CAD 4.5 million. CI
Rozdil Capital Corporation Reports Earnings Results for the Second Quarter Ended August 31, 2020 CI
Rozdil Capital Corporation Reports Earnings Results for the Full Year Ended February 29, 2020 CI
Rozdil Capital Corporation Reports Earnings Results for the Third Quarter Ended November 30, 2019 CI
More news
Rozdil Capital Corporation is a Canada-based capital pool company. The principal business of the Company is the identification and evaluation of assets or businesses with a view to completing a qualifying transaction. The Company has not commenced operations and has no assets.
Sector
-
More about the company